DOCSLIB.ORG

ECG for All Patients in the PACU: Some Say, Why? I Say, Why Not?

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ECG for All Patients in the PACU: Some Say, Why? I Say, Why Not? Volume 33 Issue 2 Article 6 6-1-2020 ECG for all patients in the PACU: Some say, why? I say, why not? Paula Foran [email protected] Follow this and additional works at: https://www.journal.acorn.org.au/jpn Part of the Health Services Administration Commons, Health Services Research Commons, Perioperative, Operating Room and Surgical Nursing Commons, and the Surgery Commons This work is licensed under a Creative Commons Attribution 4.0 License. Recommended Citation Foran, Paula (2020) "ECG for all patients in the PACU: Some say, why? I say, why not?," Journal of Perioperative Nursing: Vol. 33 : Iss. 2 , Article 6. Available at: https://doi.org/10.26550/2209-1092.1087 https://www.journal.acorn.org.au/jpn/vol33/iss2/6 This Discussion paper is brought to you for free and open access by Journal of Perioperative Nursing. It has been accepted for inclusion in Journal of Perioperative Nursing by an authorized editor of Journal of Perioperative Nursing. Discussion paper Author Dr Paula Foran ECG for all patients in the PACU: PhD, RN, FACORN, FACPAN, MACN Some say, why? I say, why not? Abstract Currently in many Australian hospitals, electrocardiogram (ECG) leads are removed after the operative process and, despite the machines being freely available in the Post Anaesthesia Care Unit (PACU), they are not connected to all patients. There are many evidence-based reasons why an ECG would be advantageous for perioperative patient safety, including the detection of often asymptomatic conditions such as myocardial injury after non-cardiac surgery (MINS) and new-onset atrial fibrillation, which has been shown to increase the risk of stroke. Advantages may also be seen in saving precious minutes in a cardiac arrest, and the ability for nurses to constantly observe ECG rhythms strips as a learning tool. The aim of this discussion paper is to challenge health care professionals’ thinking about the use of ECG monitoring for the entire perioperative journey and inspire readers to implement this patient safety initiative. Keywords: arrythmia detection, atrial fibrillation, monitoring, PACU, perioperative safety, stroke. Introduction safest perioperative journey for all patients without differentiation. We In October 1997, at South West assumed that when new monitoring Healthcare in Warrnambool, a became available, all other Australian Victorian regional health care health care facilities would do facility, we proudly moved into our the same. Perhaps because of our new operating suite. The new PACU regional locality, it was many years was fitted with state-of-the-art later that we realised this was not monitoring for every bay, something the case. quite new for the times. At that time, I was one of the associate While internationally commonplace, charge nurses for the PACU. In ECG monitoring is not currently consultation with the perioperative mandatory for PACU patients in service manager, we believed that Australia, despite several nursing now we were provided with this new texts recommending this practice1,2. equipment, we would connect all However, a growing number of health available monitoring capabilities, care facilities in Australia have including pulse oximetry, 3-lead recognised the great advantages electrocardiogram (ECG) and of ECG monitoring and have automatic blood pressure monitoring, implemented 3- or 5-lead ECG to our patients. Monitoring was rhythm strips as standard monitoring connected to all patients in stage 1 for all post-operative patients in PACU, regardless of age or procedure. stage 1 PACU. It was felt that if we distinguished This discussion paper will investigate between patients, this may become evidence surrounding why ECG a difficult decision for staff, and monitoring in the PACU would be with the realisation that, albeit rare, a valuable addition, providing a cardiac events can occur in healthy safer standard of care for Australian patients, we wanted to ensure the e-26 Journal of Perioperative Nursing Volume 33 Number 2 Winter 2020 acorn.org.au patients. This will be presented under South Africa revealed comparable reminds us that, while uncommon, four themes: results to the VISION cohort5. cardiac arrests occur during the perioperative journey9. Findings 1. myocardial injury after non- New onset perioperative atrial revealed that 28 arrests occurred cardiac surgery (MINS) fibrillation (AF) and stroke intra-operatively, five in the PACU and 2. new onset perioperative atrial Salient research conducted by three post-operatively on a ward9. Of fibrillation (AF) and stroke Gialdini et al. in 2014 informed us these, 15 cases involved emergency 3. cardiac arrest that new-onset perioperative AF surgeries, three were semi-elective is the most common arrhythmia but the majority, 18 cases, occurred 4. looking and learning. reported in perioperative patients6. during routine elective surgery When commencing their research revealing that all patients are at Discussion into perioperative AF, this common risk9. These figures are not surprising The PACU was first developed in arrythmia had been viewed as a when we remember that many 1751 by surgeons who realised their self-limited transient response to of the complications seen in the immediate post-operative patients physiological stress, however the operating suite, such as hypothermia, were unstable and would require a long-term risk of stroke after AF hypoxemia and hypovolemia, are safe environment where they could was unclear6. Findings revealed known causes of cardiac arrest. be carefully monitored by specialist that from a cohort of 1 729 360 One of the core nursing nurses until they were deemed eligible patients, 24 711 (1.43%; 95% competencies that stage 1 PACU ‘ward ready’3. Despite updates in CI, 1.41%–1.45%) were diagnosed with nurses are required to meet is anaesthesia and surgery, the role new-onset perioperative AF during advanced life support (ALS), including of the PACU nurse has remained their perioperative journey with paediatric ALS if paediatric patients relatively unchanged; it requires 13 952 (0.81%; 95% CI, 0.79%–0.82%) are cared for in the PACU10. In any attention to critical evaluation and experiencing a stroke after discharge. medical emergency, early recognition stabilisation of immediate post- These findings included both cardiac is believed to be the most essential operative patients with an emphasis and non-cardiac participants6. A step to a positive outcome11. When on the need for anticipating, recent systematic review including patients are not connected to ECG recognising and, hopefully, 3 536 291 patients from fourteen in the PACU and the patient suffers preventing complications3. In many studies conducted by Australian a cardiac arrest, minutes may be health care facilities only high-risk researchers supported the previous wasted confirming an arrest has patients are connected to an ECG in findings revealing a 2.5-fold increase occurred; however, when an ECG trace the PACU. in stroke after new-onset AF in confirms a shockable rhythm such as non-cardiac patients7. Interestingly, ventricular tachycardia or ventricular Myocardial injury after non- it was revealed that an increased fibrillation, nurses immediately know cardiac surgery (MINS) trend in the AF was noted in studies what they are dealing with and vital where continuous, as opposed to A large multicentre, international minutes may be saved. Connecting ‘opportunistic’, cardiac monitoring trial conducted in 2012 (Vascular a patient to an automated external was employed7. Recent Japanese Events In Non-cardiac Surgery defibrillator (AED) at the earliest research revealed that of non-cardiac Patients Cohort Evaluation study – possible moment is vital for patients patients who experienced new- VISION) investigated the mortality who require this therapy, as survival onset AF, 92 per cent of subsequent associated with perioperative rates decrease by approximately episodes were asymptomatic8 elevated troponin levels in patients seven to ten per cent every minute providing further evidence that ECG (n=15,133) from North and South without defibrillation12. America, Australia, Europe and Asia4. monitoring of all patients in PACU The 30-day mortality was found to would provide greater patient safety Looking and learning be independently associated with in the ability to diagnose AF post- Much of the learning involved in MINS and 84 per cent of myocardial operatively. interpreting abnormal arrythmias is injury patients were asymptomatic, Cardiac arrest to first understand what is normal. resulting in missed diagnosis in the This occurs by regular observation of vast majority of patients with MINS4. The Victorian Consultative Council a normal ECG trace. When unstable More recent research conducted in on Anaesthetic Mortality and patients or those with a known Morbidity Triennial report 2015–2017 cardiac condition are admitted to the Journal of Perioperative Nursing Volume 33 Number 2 Winter 2020 acorn.org.au e-27 PACU and staff are asked to connect throughout the entire perioperative 5. Coetzee E, Biccard B, Dyer R, Meyersfeld an ECG to a patient, if the PACU nurse journey. N, Chishala C, Mayosi B. Incidence of myocardial injury after non-cardiac surgery: has not been regularly observing This discussion paper has provided Experience at Groote Schuur Hospital, normal ECG rhythms, and maintaining information about learning Cape Town, South Africa. S Afr Med J familiarity with the diagnosis of 2018;108(5):408–412. DOI: 10.7196/SAMJ.2018. and evidence related to several arrythmias, it is likely they may have v108i5.12784. cardiovascular conditions that are lost some of their skills. 6. Gialdini G, Nearing K, Bhave P, Bonuccelli asymptomatic and may be present U, Iadecola C, Healey J et al. Perioperative There has never been a more salient in seemingly uneventful surgical atrial fibrillation and the long-term risk of time to remember that PACU nurses procedures. In many health care ischemic stroke. JAMA 2014;312(6):616–622. DOI: 10.1001/jama.2014.9143. are often asked to care for unwell facilities early signs of these 7. Koshy AN, Hamilton G, Theuerle J, Thijs V, patients.
Load more

Recommended publications
  • Medical Policy
    bmchp.org | 888-566-0008 wellsense.org | 877-957-1300 Medical Policy Ambulatory Cardiac Monitors (Excluding Holter Monitors) Policy Number: OCA 3.35 Version Number: 24 Version Effective Date: 03/01/21 + Product Applicability All Plan Products Well Sense Health Plan Boston Medical Center HealthNet Plan Well Sense Health Plan MassHealth Qualified Health Plans/ConnectorCare/Employer Choice Direct Senior Care Options ◊ Notes: + Disclaimer and audit information is located at the end of this document. ◊ The guidelines included in this Plan policy are applicable to members enrolled in Senior Care Options only if there are no criteria established for the specified service in a Centers for Medicare & Medicaid Services (CMS) national coverage determination (NCD) or local coverage determination (LCD) on the date of the prior authorization request. Review the member’s product-specific benefit documents at www.SeniorsGetMore.org to determine coverage guidelines for Senior Care Options. Policy Summary The Plan considers the use of ambulatory cardiac monitors in the outpatient setting to be medically necessary if the type of ambulatory cardiac monitor is covered for the Plan member and ALL applicable Plan criteria are met, as specified in the Medial Policy Statement and Limitations sections of this policy. Plan prior authorization is required. When the device is covered for the member, medically necessary ambulatory cardiac monitors utilized in the outpatient setting may include ambulatory cardiac event monitors, mobile cardiac outpatient telemetry, and/or single-use external ambulatory electrocardiographic monitoring patches available by prescription. Ambulatory Cardiac Monitors (Excluding Holter Monitors) + Plan refers to Boston Medical Center Health Plan, Inc. and its affiliates and subsidiaries offering health coverage plans to enrolled members.
    [Show full text]
  • Bed-Based Ballistocardiography: Dataset and Ability to Track Cardiovascular Parameters
    sensors Article Bed-Based Ballistocardiography: Dataset and Ability to Track Cardiovascular Parameters Charles Carlson 1,* , Vanessa-Rose Turpin 2, Ahmad Suliman 1 , Carl Ade 2, Steve Warren 1 and David E. Thompson 1 1 Mike Wiegers Department of Electrical and Computer Engineering, Kansas State University, Manhattan, KS 66506, USA; [email protected] (A.S.); [email protected] (S.W.); [email protected] (D.E.T.) 2 Department of Kinesiology, Kansas State University, Manhattan, KS 66506, USA; [email protected] (V.-R.T.); [email protected] (C.A.) * Correspondence: [email protected] Abstract: Background: The goal of this work was to create a sharable dataset of heart-driven signals, including ballistocardiograms (BCGs) and time-aligned electrocardiograms (ECGs), photoplethysmo- grams (PPGs), and blood pressure waveforms. Methods: A custom, bed-based ballistocardiographic system is described in detail. Affiliated cardiopulmonary signals are acquired using a GE Datex CardioCap 5 patient monitor (which collects ECG and PPG data) and a Finapres Medical Systems Finometer PRO (which provides continuous reconstructed brachial artery pressure waveforms and derived cardiovascular parameters). Results: Data were collected from 40 participants, 4 of whom had been or were currently diagnosed with a heart condition at the time they enrolled in the study. An investigation revealed that features extracted from a BCG could be used to track changes in systolic blood pressure (Pearson correlation coefficient of 0.54 +/− 0.15), dP/dtmax (Pearson correlation coefficient of 0.51 +/− 0.18), and stroke volume (Pearson correlation coefficient of 0.54 +/− 0.17). Conclusion: A collection of synchronized, heart-driven signals, including BCGs, ECGs, PPGs, and blood pressure waveforms, was acquired and made publicly available.
    [Show full text]
  • Clinical Research Protocol
    DOCUMENT APPROVAL PAGE Document Number: Rev: Page: 90D0167 C 1 of 32 Title: Ambulatory Remote Patient Monitoring using the µCor Heart Failure and Arrhythmia Management System (PATCH) Feasibility Study: Protocol NCT04512703 Author: Ramu Perumal, PhD Date: 9-February-2018 Approvals ( “ ” indicates approval signature required) Medical Affairs: Date: Marketing: Date: Clinical Operations: Date: Billing/Reimbursement: Date: IE/QE Engineering: Date: Support Service: Date: Service Operations: Date: Technology Applications: Date: OEM Regulatory: Date: OEM Engineering: Date: Documentation Control: Date Archived: Electronic File info: (if applicable) *If multiple files (such as multiple sheets of a drawing) list file info separately File name: Size (in bytes) Time & Date (or Date & Time) 90D0167_revC.docx Transferred File info: (To be completed by Documentation Control) File name: Size (in bytes) Time & Date (or Date & Time) 90d0167_revc.doc 90d0167_revc.pdf ZOLL Services Form Number: 90A0001-A01 Form REV Level: A DOCUMENT REVISION HISTORY PAGE Document Number: Rev: Page: 90D0167 C 2 of 32 Title: Ambulatory Remote Patient Monitoring using the µCor Heart Failure and Arrhythmia Management System (PATCH)Feasibility Study: Protocol Revision History Of Document CO Rev Number Description of Change Author Effective Date FI NA First version RP 7/17/17 A NA Changed the device name from Continuous Mobile Cardiac RP 8/22/17 Telemetry System to uCor Heart Failure and Arrhythmia Management System. B NA The following changes were made: RP 10/16/17 1. Removed CE-mark reference for the device 2. Subjects no longer have to send photographs of the skin and device placement. Instead, they will note their skin condition and device location on the subject diary 3.
    [Show full text]
  • Appropriate Usage of Continuous Cardiac Monitoring in the Inpatient Setting: a Literature Review
    Arch Intern Med Res 2021; 4 (2): 062-065 DOI: 10.26502/aimr.0057 Review Article Appropriate Usage of Continuous Cardiac Monitoring in the Inpatient Setting: A Literature Review Sara Whyte1, Krishna Vedala1*, Philip T Sobash1, Raghuveer Vedala2, Kalyan Gonugunta1 Review Article 1Department of Internal Medicine, White River Health System, Arkansas, USA 2Department of Family Medicine, University of Oklahoma Health Sciences Center, Oklahoma, USA *Corresponding author: Krishna Vedala, Department of Internal Medicine, White River Health System, Batesville, Arkansas, USA Received: 31 March 2021; Accepted: 08 April 2021; Published: 21 April 2021 Citation: Sara Whyte, Krishna Vedala, Philip T Sobash, Raghuveer Vedala, Kalyan Gonugunta. Appropriate Usage of Continuous Cardiac Monitoring in the Inpatient Setting: A Literature Review. Archives of Internal Medicine Research 4 (2021): 062-065. Keywords: Telemetry ed, life-threatening arrhythmias [5, 6]. Electrocardiographic monitoring (telemetry) in the In patients presenting with chest pain and indications for inpatient setting has significant utility, but is constrained acute coronary syndrome (ACS), telemetry is warranted by rising healthcare costs, rare detection of significant in the early phases (<24 hours) for intermediate- or events and potential for great alert fatigue [1, 2]. In high-risk non-ST elevated-ACS or ST-segment- 2017, the American Heart Association (AHA) published elevation of myocardial infarction (STEMI), until ruled updated practice standards for telemetry monitoring that out [3]. Cardiac arrest is the leading cause of death addressed overuse, appropriate use, alarm management among adults in the United States, and most common and documentation in electronic medical records [3, 4]. cause of death after MI [7]. In patients with myocardial Here, we review their recommendations for indication infarction (MI), after cardiac arrest, during temperature for telemetry utilization on the hospital floor.
    [Show full text]
  • Cardiac Monitoring Infographic
    Cardiac monitors have been used for years to help physicians determine if patients are experiencing EVOLUTION OF THE irregular heartbeats (arrhythmias) that are causing recurrent fainting, palpitations, unexplained stroke, or atrial fibrillation. Over time, these devices have grown smaller—and smarter—and the latest devices ™ are revolutionizing the world of cardiac monitoring. Reveal LINQ CARDIAC MONITOR Insertable Cardiac Monitor Cardiac monitors have evolved from large, wired, external devices to small and simple, yet powerful, systems that monitor a patient’s MCT Wire-free Wearable Miniaturized Insertable 1 Holter Monitor Event Monitor heartbeat for up to three years, (Mobile Cardiac Telemetry) MCT Monitor Cardiac Monitor without the bulk and inconvenience of traditional devices. KEY External, adhesive-backed = Duration of use monitor improves patient Nearly invisible on most comfort and convenience patients; approximately = Not water resistant with “peel and stick” 1/3 the size of an AAA battery and safe for use simplicity and remote in an MRI setting. = Water resistant monitoring capabilities. 24–48 hours Up to 30 days Up to 30 days Up to 30 days Up to 3 years = Worn externally = Worn internally = Device automatically transmits data to physicians via wireless connectivity 1. Reference the Reveal LINQ ICM Clinician Manual for usage parameters. Brief Statement: REVEAL LINQ™ LNQ11 Insertable Cardiac Monitor and Patient Assistant Patient Assistant Operation of the Patient Assistant near sources of electromagnetic interference, such as
    [Show full text]
  • MEDICAL COVERAGE POLICY SERVICE: Cardiac Monitoring
    MEDICAL COVERAGE POLICY SERVICE: Cardiac Monitoring - Outpatient Policy Number: 065 Effective Date: 03/01/2021 Last Review: 01/28/2021 Next Review Date: 01/28/2022 Important note Unless otherwise indicated, this policy will apply to all lines of business. Even though this policy may indicate that a particular service or supply may be considered medically necessary and thus covered, this conclusion is not based upon the terms of your particular benefit plan. Each benefit plan contains its own specific provisions for coverage and exclusions. Not all benefits that are determined to be medically necessary will be covered benefits under the terms of your benefit plan. You need to consult the Evidence of Coverage (EOC) or Summary Plan Description (SPD) to determine if there are any exclusions or other benefit limitations applicable to this service or supply. If there is a discrepancy between this policy and your plan of benefits, the provisions of your benefits plan will govern. However, applicable state mandates will take precedence with respect to fully insured plans and self-funded non-ERISA (e.g., government, school boards, church) plans. Unless otherwise specifically excluded, Federal mandates will apply to all plans. With respect to Medicare-linked plan members, this policy will apply unless there are Medicare policies that provide differing coverage rules, in which case Medicare coverage rules supersede guidelines in this policy. Medicare-linked plan policies will only apply to benefits paid for under Medicare rules, and not to any other health benefit plan benefits. CMS's Coverage Issues Manual can be found on the CMS website.
    [Show full text]
  • Ambulatory Event Monitors
    Corporate Medical Policy Ambulatory Event Monitors File Name: a mbulatory_event_monitors Origination: 10/2000 Last CAP Review: 10/2020 Next CAP Review: 10/2021 Last Review: 10/2020 Description of Procedure or Service Various devices are available for outpatient cardiac rhythm monitoring. These devices differ in the types of monitoring leads used, the duration and continuity of monitoring, the ability to detect arrhythmias without patient intervention, and the mechanism of delivery of the information from pa tient to clinicia n. These devices may be used to evaluate symptoms suggestive of arrhythmias (eg, syncope, palpitations), and may be used to detect atrial fibrillation (AF) in patients who have undergone cardiac ablation of AF or who have a history of cryptogenic stroke. Ca rdiac monitoring is routinely used in the inpatient setting to detect acute changes in heart rate or rhythm that may need urgent response. For some clinical conditions, a more prolonged period of monitoring in the ambulatory setting is needed to detect heart rate or rhythm abnormalities that may occur infrequently. These cases may include the diagnosis of arrhythmias in patients with signs and symptoms suggestive of a rrhythmias, as well a s, the evaluation of paroxysmal a tria l fibrilla tion (AF). Arrhythmia Detection in Patients With Signs/Symptoms of Arrhythmia Ca rdiac a rrhythmias may be suspected because of symptoms suggestive of a rrhythmias, including palpitations, dizziness, or syncope or presyncope, or because of abnormal heart rate or rhythm noted on exam. A full discussion of the differential diagnosis and evaluation of each of these symptoms is beyond the scope of this review, but some general principles on the use of ambulatory monitoring are discussed.
    [Show full text]
  • Regional ST-Segment Monitoring Self
    ST-Segment Monitoring Self-Learning Package 1 Page This self-learning package is intended to be supplementary information and is not intended to replace Policy and Procedures, Guidelines and/or critical thinking. Developed by: SBH Cardiac Sciences/Critical Care Clinical Educators Reviewed and Revised by: The Regional Critical Care Policy and Procedure 2 Committee Page This self-learning package is intended to be supplementary information and is not intended to replace Policy and Procedures, Guidelines and/or critical thinking. Table of Contents: Purpose, Objectives and Instructions 4 Normal Cardiac Cycle Review 5 Clinical Conditions for ST-Segment Monitoring 6 Lead Placement 6 Ensuring ST-Segment Accuracy 7 Considerations with ST-Segment Monitoring 7 What to do if ST-Segment Changes are Noted 8 What to Document and Where 8 In Summary 9 Reference 9 Appendix A: Philips Monitor Setup 11 Appendix B: Spacelabs Monitor Setup 13 Appendix C: Documentation Examples 15 Validation Exercise (site/program specific) See Educator 3 Page This self-learning package is intended to be supplementary information and is not intended to replace Policy and Procedures, Guidelines and/or critical thinking. PURPOSE The purpose of this package is to provide the nurse working in cardiac monitored areas education to care for patients requiring ST-segment monitoring. OBJECTIVES After completing this package, the learner will be able to: 1. Explain the importance of ST-segment monitoring for different patient populations. 2. Identify appropriate ECG lead placement based on patient population. 3. Identify the appropriate assessment, interpretation, treatment, and documentation for ST-segment monitoring. INSTRUCTIONS This package is designed to be a supplementary review to any previously acquired knowledge and experience regarding ST-segment monitoring.
    [Show full text]
  • Current Use of the Pulmonary Artery Catheter in Cardiac Surgery a Survey Study
    Current Use of the Pulmonary Artery Catheter in Cardiac Surgery: A Survey Study Onkar Judge, MD,* Fuhai Ji, MD,*† Neal Fleming, MD, PhD,* and Hong Liu, MD* Objective: Because of its invasive nature, debated effect (29.6%) did more than 800 cases annually. For cases using on patient outcome, and the development of alternative cardiopulmonary bypass, 583 (68.2%) of the respondents hemodynamic monitoring technologies, the intraoperative used a PAC more than 75% of the time, while 30 (3.5%) did use of the pulmonary artery catheter (PAC) has significantly not use the PAC at all. decreased. The authors conducted a survey of the members of Ninety-four percent of respondents used transesophageal the Society of Cardiovascular Anesthesiologists (SCA) to assess echocardiography (TEE) as part of the intraoperative mon- current use of the PAC and alternative hemodynamic monitor- itoring. When not using a PAC, FloTrac/Vigileo was the ing technologies in patients undergoing cardiac surgery. alternative cardiac monitoring modality in 15.2% of the Design: A survey study. responses. Similar trends in monitor preferences were seen Setting: Hospitals in North America, Europe, Asia, Aus- in off-pump coronary artery bypass grafting and minimally tralia, New Zealand, and South America. invasive/robotic heart surgery. Participants: SCA members in North America, Europe, Conclusions: The results of this study suggested that a Asia, Australia, New Zealand, and South America. majority of the respondents still prefer to use the PAC for Interventions: The survey was e-mailed by the SCA to most cardiac surgeries. Subgroup analysis of the data roughly 6,000 of its members.
    [Show full text]
  • Cardiac Monitoring and Qtc Assessment Guidelines
    Cardiac Monitoring and QTc Assessment Guidelines Revised 4/9/2020 2:58 PM Many of the treatments used for COVID-19 patients have QTc-prolonging potential – these treatments include hydroxychloroquine (Plaquenil) or chloroquine, azithromycin (Zithromax), and lopinavir/ritonavir (Kaletra). When used in combination, or with any other known QTc prolonging agents (e.g. amiodarone, sotalol, haloperidol, etc.), these agents can have additive QTc-prolonging effects and therefore, increased associated risk of arrhythmic death. A risk score for drug-associated QTc prolongation has been derived and validated by Tisdale and colleagues for prediction of drug-associated QT prolongation among cardiac care unit-hospitalized patients (Table 1). A Tisdale score of ≤ 6 predicts low risk, 7-10 medium risk, and ≥ 11 high risk of drug-associated QT prolongation (Table 2). Suggested Monitoring for Inpatient Clinical Use Patients admitted with COVID-19 are likely to have longer baseline QTc and have higher potential arrhythmic risks as a result of the metabolic and physiologic sequelae of their illness, and a typically greater burden of comorbid disease. However, given the severity of illness, hospitalized and critically ill patients may also derive the most benefit from potentially effective therapies. The goal of QTc screening in this setting is not to identify patients whom are not candidates for therapy, but to identify those who are at increased risk for torsades de pointes so aggressive countermeasures may be implemented. • EKG/Telemetry: o To minimize healthcare associate exposure and PPE usage: ▪ EKGs can be done by either the ECG technician (if available) or the bedside nurse during the normal course of patient care.
    [Show full text]
  • Cardiac Monitoring Devices in the Outpatient Setting
    Corporate Medical Policy Cardiac Monitoring Devices in the Outpatient Setting File Name: cardiac_monitoring_devices_in_the_outpatient_setting Origination: 9/2010 Last CAP Review: 10/2020 Next CAP Review: 10/2021 Last Review: 10/2020 Description of Procedure or Service A variety of outpatient cardiac monitoring devices are available to prompt a patient to seek medical help for prevention or early intervention of an impending or ongoing cardiac event. Example s include hemodynamic monitors to decrease episodes of acute decompensation in patients with heart failure by detecting physiologic changes that precede clinical symptoms, and cardiac ischemia monitors to detect electrocardiogram changes to alert the patient of a potential ongoing acute coronary event. Cardiac Hemodynamic Monitors for Heart Failure Patients with chronic heart failure are at risk of developing acute decompensated heart failure, often requiring hospital admission. Patients with a history of acute decompensation have additional risk of future episodes of decompensation, and death. Reasons for the transition from a stable, chronic state to an acute, decompensated state include disease progression, as well as acute coronary ischemic events and dysrhythmias. While precipitating factors are frequently not identified, the most common preventable cause is noncompliance with medication and dietary regimens. Strategies for reducing decompensation, and thus the need for hospitalization, are aimed at early identification of patients at risk for imminent decompensation. Programs for early identification of heart failure are characterized by frequent contact with patients to review signs and symptoms with a healthcare provider, and with education or adjustment of medications as appropriate. These encounters may occur face-to-face in the office or at home, or via transmission of symptoms and conventional vital signs, including weight, via cellular or computed technology.
    [Show full text]
  • Telemetry– Related Events
    A Brief Analysis of Telemetry– Related Events Elizabeth Kukielka, PharmD, MA, RPh, Kelly R. Gipson, BSN, RN & Rebecca Jones, MBA, RN DOI: 10.33940/biomed/2019.12.4 Abstract monitoring submitted to PA-PSRS. User errors accounted for nearly half (47.1%, Successful telemetry monitoring relies on 263 of 558) of events in the analysis. The timely clinician response to potentially life- most common event subtypes included: threatening cardiac rhythm abnormalities. errors involving batteries in telemetry Breakdowns in the processes and procedures monitoring equipment (14.0%); errors associated with telemetry monitoring, as in which patients were not connected to well as improperly functioning telemetry telemetry monitoring equipment as ordered monitoring equipment, may lead to events (12.9%); errors involving broken, damaged, that compromise patient safety. An analysis or malfunctioning telemetry monitoring of reports submitted to the Pennsylvania equipment (10.9%); and errors in which Patient Safety Reporting System (PA-PSRS) patients were connected to the wrong from January 2014 through December 2018 telemetry monitoring equipment (9.0%). identified 558 events specifically involving interruptions or failures associated with Keywords: telemetry, cardiac monitoring, telemetry monitoring equipment or with the patient safety, alarm management, healthcare providers responsible for setting cardiac arrhythmias, communication, up and maintaining proper functioning of equipment malfunction, monitor technician that equipment. The analysis highlighted
    [Show full text]